AbbVie Deutschland GmbH

WO 2024243450

MÉTHODES DE TRAITEMENT UTILISANT DES CONJUGUÉS ANTICORPS-MÉDICAMENT ANTI-C-MET

Expires Wed Nov 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3266054

COMPOSÉS DE N-MÉTHYL-4-(QUINOLIN-2-YL)PYRIDIN-2-AMINE

Expires Wed Mar 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3259391

POLYTHÉRAPIE ANTI-GARP-TGF-β1/PD-1

Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3245150

COMBINAISONS AVEC UN ANTICORPS ANTI-CD39 HUMAIN, UN ANTICORPS ANTI-PD-1 HUMAIN ET UNE CHIMIOTHÉRAPIE CONTRE LE CANCER GASTRIQUE

Expires Wed Sep 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2023174645

ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

Expires Wed Jun 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3235096

METHODES DE TRAITEMENT DE L'ANEMIE CAUSEE PAR UNE MALADIE RENALE

Expires Wed May 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3207179

METHODES DE TRAITEMENT DE LA MALADIE DE CROHN ET DE LA COLITE ULCEREUSE

Expires Wed Jul 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2022169620

SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

Expires Wed May 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3177888

ANTICORPS ANTI-HEMOJUVELINE (HJV) DE TRAITEMENT DE L'ANEMIE DE MALADIES CHRONIQUES

Expires Wed Nov 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2021128573

DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX

Expires Wed May 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3668502

MAKROCYCLISCHE MCL-1-INHIBITOREN UND VERFAHREN ZUR VERWENDUNG

Expires Tue Jun 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2020155578

Pharmaceutical Formulations for Subcutaneous Administration

Expires Wed May 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3094934

FORMULATIONS AQUEUSES STABLES D'ANTICORPS ANTI-TAU

Expires Wed Sep 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2019144465

Macrocyclic MCL-1 inhibitors and methods of use

Expires Wed May 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2019048531

NANOPARTICULES MODIFIÉES PAR L'ALBUMINE PORTANT UN LIGAND DE CIBLAGE

Expires Wed Mar 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2019055264

Macrocyclic MCL-1 inhibitors and methods of use

Expires Wed Feb 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2019016112

COMPOSÉS DE QUINOLÉINE À SUBSTITUTION EN POSITIONS 1, 2, 3 ET 4 UTILISÉS EN TANT QUE MODULATEURS DE S1P

Expires Wed Jan 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2018175449

COMPOSÉS DE PROLINE AMIDE ET LEURS ANALOGUES D'AZÉTIDINE PORTANT UN RADICAL BENZYLE À SUBSTITUTION SPÉCIFIQUE

Expires Wed Sep 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2018083171

COMPOSÉS SPIRO EN TANT QUE MODULATEURS DE S1P

Expires Thu May 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017349653

METHODS FOR TREATING SPINAL CORD INJURY AND PAIN

Expires Wed Dec 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017260158

QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

Expires Wed Sep 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017174672

FUSED (HETERO)CYCLIC COMPOUNDS AS S1P MODULATORS

Expires Wed Jun 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017089458

HEXAHYDROPYRAZINOBENZ- OU -PYRIDO-OXAZÉPINES TRANSPORTANT UN SUBSTITUANT CONTENANT DE L'OXYGÈNE ET SON UTILISATION POUR LE TRAITEMENT D'AFFECTIONS CONDITIONNÉES PAR 5-HT2C

Expires Wed May 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)